The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States

Ganz, Michael L.; Shah, Dhvani; Gidwani, Risha; Filonenko, Anna; Su, Wenqing; Pocoski, Jennifer; Law, Amy

doi:10.1016/j.jval.2012.11.011

Cited by 15 publications

(12 citation statements)

References 21 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 94 LNG-IUS 20 treatment resulted in the fewest hysterectomies and most quality-adjusted life-years, and it was less costly. 95 In another Cochrane Database Systematic Review , hysterectomy was found to reduce menstrual bleeding better than the LNG-IUS 20 at 1 year, but there was no evidence of a difference in patient satisfaction rates between surgery and LNG-IUS. 96 In that analysis, adverse events, such as bleeding and spotting, were more likely to occur with LNG-IUS, but surgery was more likely to cause serious complications.…”

Section: Iuds Currently Available In the Usmentioning

confidence: 96%

New developments in intrauterine device use: focus on the US

Nelson¹,

Massoudi²

2016

OAJC

View full text Add to dashboard Cite

Many more women in the US today rely upon intrauterine devices (IUDs) than in the past. This increased utilization may have substantially contributed to the decline in the percentage of unintended pregnancies in the US. Evidence-based practices have increased the number of women who are medically eligible for IUDs and have enabled more rapid access to the methods. Many women enjoy freedom to use IUDs without cost, but for many the impact of the Affordable Care Act has yet to be realized. Currently, there are three hormonal IUDs and one copper IUD available in the US. Each IUD is extremely effective, convenient, and safe. The newer IUDs have been tested in populations not usually included in clinical trials and provide reassuring answers to older concerns about IUD use in these women, including information about expulsion, infection, and discontinuation. On the other hand, larger surveillance studies have provided new estimates about the risks of complications such as perforation, especially in postpartum and breastfeeding women. This article summarizes significant features of each IUD and provides a summary of the differences to aid clinicians in the US and other countries in advising women about IUD choices.

show abstract

Section: Iuds Currently Available In the Usmentioning

confidence: 96%

New developments in intrauterine device use: focus on the US

Nelson¹,

Massoudi²

2016

OAJC

View full text Add to dashboard Cite

show abstract

“…In fact, the Mirena IUD is FDA approved for the management of menorrhagia. The LNG-IUD has been studied and found beneficial for women with chronic amenorrhea from other medical conditions as well as gynecologic disorders like menorrhagia and dysmenorrhea [47,48].…”

Section: Noncontraceptive Benefits Of Iudsmentioning

confidence: 99%

Intrauterine Contraception

Whaley

Burke

2015

Womens Health (Lond Engl)

View full text Add to dashboard Cite

Intrauterine devices (IUDs) are effective, reversible forms of contraception with high patient satisfaction and continuation. IUDs can be safely used by most women and should be considered the first-line method of contraception for all women. This descriptive review will discuss the clinical issues associated with IUDs - including management of side effects, noncontraceptive uses and insertion and removal. When the burdens of cost are removed, women are more likely to select and IUDs. Health policy changes that increase insurance coverage for contraception will improve access to IUDs. IUDs remain an underutilized form of contraception in USA and efforts to improve availability and access to long-acting reversible contraception methods is needed to optimize their use.

show abstract

“…The authors recommended the use of the LNG-IUS for the management of such bleeding, over other effective treatments such as combined oral contraceptives, non-steroidal antiinflammatory drugs and luteal phase progestogens (Matteson et al 2013). In the US, it has been suggested that the LNG-IUS may be the most cost effective intervention for those who wish to preserve fertility (Ganz et al 2013).…”

Section: Reduced Bleedingmentioning

confidence: 99%

Medicines For Women

Harrison‐Woolrych¹

2015

View full text Add to dashboard Cite

The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States

Cited by 15 publications

References 21 publications

New developments in intrauterine device use: focus on the US

New developments in intrauterine device use: focus on the US

Intrauterine Contraception

Medicines For Women

Contact Info

Product

Resources

About